PharmaEssentia Corporation (6446.TW)
TWD 530.0
(-1.49%)
TWD 530.0
(-1.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -705.56 Million | -1.5 Billion | -2.46 Billion | -1.45 Billion | -945.02 Million |
| Net Income | -986.93 Million | -1.84 Billion | -2.81 Billion | -1.94 Billion | -842.99 Million |
| Depreciation & Amortization | 268.75 Million | 227.91 Million | 227.08 Million | 174.78 Million | 136.77 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 710.2 Million | 216.2 Million | 501.51 Million | 53.76 Million | 132.8 Million |
| Change in working capital | -677.06 Million | -109.97 Million | -390.92 Million | 264.65 Million | -394.49 Million |
| Other non-cash items | -538.43 Million | -21.91 Million | 5.32 Million | -7.79 Million | 22.88 Million |
| Investing Cash Flow | -486.65 Million | -1.24 Billion | -78.17 Million | -302.19 Million | -237.86 Million |
| Investments in PPE | -1.32 Billion | -320.74 Million | -97.87 Million | -207.51 Million | -120.73 Million |
| Acquisitions | - | - | - | -1.73 Million | - |
| Investment purchases | 874.14 Million | -989.12 Million | 37.57 Million | -71.04 Million | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -33.1 Million | 67.06 Million | -17.87 Million | -22.13 Million | -117.13 Million |
| Financing Cash Flow | 10.45 Billion | 9.57 Billion | 2.8 Billion | 3.56 Billion | 411.49 Million |
| Debt repayment | -984.91 Million | -961.84 Million | -36.56 Million | -71.6 Million | -67.26 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -2.71 Billion | - | -87.5 Million | -257.23 Million | -2 Million |
| Common Stock Issuance | 14.33 Billion | 8.74 Billion | 3.04 Billion | 3.83 Billion | - |
| Other Financing Activities | 13.32 Billion | 9.7 Billion | 3.01 Billion | 3.88 Billion | -2 Million |
| Accounts receivables | -513.65 Million | -332.6 Million | -15.44 Million | 62.49 Million | -176.36 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | -356.6 Million | -240.66 Million | -466.53 Million | -137.52 Million | -221.88 Million |
| Other working capital | 295.24 Million | 408.67 Million | 91.74 Million | 317.86 Million | 3.75 Million |
| Cash at beginning of period | 10.3 Billion | 3.45 Billion | 3.2 Billion | 1.39 Billion | 2.16 Billion |
| Cash at end of period | 19.66 Billion | 10.3 Billion | 3.45 Billion | 3.2 Billion | 1.39 Billion |
| Capital Expenditure | -1.32 Billion | -320.74 Million | -97.87 Million | -207.51 Million | -120.73 Million |
| Effect of forex changes on cash | 100.16 Million | 19 Million | -15.24 Million | -4.18 Million | 184 Thousand |
| Net cash flow / Change in cash | 9.36 Billion | 6.85 Billion | 253.26 Million | 1.8 Billion | -771.2 Million |
| Free Cash Flow | -2.03 Billion | -1.82 Billion | -2.55 Billion | -1.66 Billion | -1.06 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 926.5 Million | 334.6 Million | -986.93 Million | -214.73 Million | 190.86 Million | -203.05 Million |
| Depreciation & Amortization | 91.18 Million | 88.55 Million | 268.75 Million | 102.37 Million | 59.41 Million | 55.94 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 52.72 Million | 50.88 Million | 710.2 Million | 72.19 Million | 130.46 Million | 138.96 Million |
| Change in working capital | -170.43 Million | -737.04 Million | -677.06 Million | -58.19 Million | 93.32 Million | -294.3 Million |
| Other non-cash items | -228.94 Million | -215.31 Million | -538.43 Million | -207.43 Million | -214.34 Million | -112.45 Million |
| Investing Cash Flow | -95.04 Million | -159.65 Million | -486.65 Million | -658.61 Million | -67.94 Million | 1.99 Billion |
| Investments in PPE | -83.85 Million | -141.18 Million | -1.32 Billion | -661.02 Million | -148.85 Million | -200.56 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -908 Thousand | -180 Thousand | 874.14 Million | -284 Thousand | 105.49 Million | 2.2 Billion |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -10.28 Million | -18.29 Million | -33.1 Million | 2.68 Million | -24.58 Million | -10.51 Million |
| Financing Cash Flow | -70.8 Million | -69.42 Million | 10.45 Billion | -39.48 Million | -2.02 Billion | 10.79 Billion |
| Debt repayment | -8.06 Million | -19.05 Million | -984.91 Million | -2.04 Million | -141.17 Million | -2.24 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -2.71 Billion | -53.7 Million | -1.91 Billion | -749.8 Million |
| Common Stock Issuance | 965 Thousand | 5.46 Million | 14.33 Billion | 63.65 Million | 59.28 Million | 13.83 Billion |
| Other Financing Activities | -4.59 Million | -11.18 Million | 13.32 Billion | 14.22 Million | -115.13 Million | 11.54 Billion |
| Accounts receivables | -434.21 Million | -363.5 Million | -513.65 Million | 88.46 Million | -237.66 Million | -308.9 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 33.44 Million | 944 Thousand | -356.6 Million | 73.84 Million | -267.04 Million | -53.68 Million |
| Other working capital | 212.19 Million | -376.15 Million | 295.24 Million | -227.19 Million | 629.79 Million | 69.73 Million |
| Cash at beginning of period | 19.19 Billion | 19.66 Billion | 10.3 Billion | 20.53 Billion | 22.04 Billion | 9.56 Billion |
| Cash at end of period | 20.06 Billion | 19.19 Billion | 19.66 Billion | 19.66 Billion | 20.53 Billion | 22.04 Billion |
| Capital Expenditure | -83.85 Million | -141.18 Million | -1.32 Billion | -661.02 Million | -148.85 Million | -200.56 Million |
| Effect of forex changes on cash | 170.32 Million | 53.27 Million | 100.16 Million | -91.57 Million | 178.68 Million | 773 Thousand |
| Net cash flow / Change in cash | 868.39 Million | -474.05 Million | 9.36 Billion | -866.59 Million | -1.51 Billion | 12.47 Billion |
| Free Cash Flow | 780.06 Million | -439.42 Million | -2.03 Billion | -737.95 Million | 259.37 Million | -508.1 Million |
SROYF
PUBLI
EUREKAI
1268
SLL
CHEF